| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.07 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.08 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |